Target intelligence / Profile preview

Signal peptide peptidase-like 2C (SPPL2C)

Target
SPPL2C
Molecular classification
Enzyme, Intramembrane aspartyl protease
01

Overview

Signal peptide peptidase-like 2C (SPPL2C) is an intramembrane aspartyl protease of the SPP/SPPL family, categorized by conserved 'YD' and 'GxGD' active site motifs located within transmembrane domains[5][2]. SPPL2C is primarily and highly expressed in the testes—particularly in spermatids—of mouse and human, where it supports male germ cell differentiation, vesicular trafficking, acrosome formation, and Ca²⁺ regulation through proteolytic cleavage of specific substrates such as phospholamban and SNARE proteins[2][3][6][7]. While other family members such as SPPL2A and SPPL2B have known immunological or pathophysiological roles, SPPL2C’s loss in mice leads to partial defects in spermatid maturation and reduced sperm motility, but maintains overall fertility. No direct human disease associations or connections to drug targeting, biomarkers, or safety concerns have been established as of current knowledge[2][4].

Other names
SPPL2CIMP5SPP-like 2CSPPL2cIMP-5Intramembrane protease 5
02

Mechanism of action

Proteolytic cleavage of transmembrane or tail-anchored proteins (e.g., SNARE proteins, phospholamban/PLN)

03

Biological functions

Intramembrane proteolysisCleavage of tail-anchored proteinsRegulation of spermatogenesisRegulation of Ca²⁺ signalingVesicular traffickingAcrosome formationProtein glycosylation
04

Disease associations

Male infertility/subfertility (spermatogenesis defects)Other (no direct link to major human diseases established)

Beyond the preview

Go deeper on Signal peptide peptidase-like 2C (SPPL2C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal peptide peptidase-like 2C (SPPL2C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call